Header Logo

Jennifer Ku

Concepts (168)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bronchiectasis
5
2023
7
3.850
Why?
Mycobacterium Infections, Nontuberculous
8
2023
12
3.510
Why?
Lung Diseases
5
2023
42
3.240
Why?
Mycobacterium avium-intracellulare Infection
3
2023
3
1.860
Why?
Mycobacterium avium Complex
4
2023
4
1.440
Why?
Medicare
4
2023
205
1.330
Why?
Nontuberculous Mycobacteria
5
2023
7
1.220
Why?
Anti-Bacterial Agents
4
2023
142
1.170
Why?
Aged
19
2025
6173
1.110
Why?
Drug Therapy, Combination
3
2023
115
1.100
Why?
Humans
36
2025
17822
1.020
Why?
Influenza Vaccines
2
2024
273
0.950
Why?
Vaccination
6
2024
655
0.940
Why?
Influenza, Human
2
2024
265
0.940
Why?
Graft Rejection
1
2024
5
0.910
Why?
United States
10
2024
4007
0.870
Why?
Aged, 80 and over
9
2024
1931
0.860
Why?
Rifamycins
1
2023
1
0.850
Why?
Opportunistic Infections
1
2023
7
0.840
Why?
Hospitalization
3
2024
810
0.830
Why?
Communicable Diseases
1
2023
15
0.830
Why?
Thoracic Surgical Procedures
1
2021
2
0.760
Why?
Pseudomonas Infections
1
2021
3
0.760
Why?
Male
20
2025
10145
0.750
Why?
Retrospective Studies
12
2024
2467
0.750
Why?
Female
22
2025
12780
0.700
Why?
Delivery of Health Care, Integrated
2
2024
537
0.630
Why?
Retinal Vasculitis
3
2014
3
0.620
Why?
Adult
19
2025
7708
0.590
Why?
Middle Aged
16
2025
8020
0.530
Why?
Rheumatic Diseases
1
2015
2
0.500
Why?
Academic Medical Centers
1
2015
30
0.490
Why?
Outpatients
1
2015
110
0.470
Why?
Disease Management
1
2015
135
0.460
Why?
Health Care Surveys
1
2015
230
0.460
Why?
Patient Satisfaction
1
2015
212
0.450
Why?
Physician-Patient Relations
1
2015
189
0.440
Why?
Visual Acuity
2
2014
21
0.440
Why?
Disinfection
1
2013
2
0.440
Why?
Ethambutol
2
2023
2
0.440
Why?
Staphylococcal Infections
1
2013
14
0.440
Why?
Skin Diseases, Infectious
1
2013
5
0.430
Why?
California
6
2025
2328
0.430
Why?
Soft Tissue Infections
1
2013
10
0.430
Why?
Cohort Studies
8
2023
2590
0.430
Why?
Herpes Zoster Vaccine
2
2024
59
0.400
Why?
Case-Control Studies
4
2024
1120
0.400
Why?
Herpes Zoster
2
2024
82
0.390
Why?
Adolescent
11
2025
3690
0.350
Why?
Rifampin
2
2023
3
0.340
Why?
Follow-Up Studies
6
2017
1219
0.340
Why?
Young Adult
9
2025
2464
0.330
Why?
Lung
2
2023
62
0.330
Why?
Risk Factors
5
2025
3362
0.320
Why?
Seasons
2
2024
105
0.290
Why?
Prospective Studies
4
2023
1286
0.260
Why?
Treatment Outcome
5
2023
1265
0.260
Why?
Regional Health Planning
1
2025
6
0.240
Why?
Tuberculosis
1
2025
23
0.240
Why?
Urinary Tract Infections
1
2024
20
0.240
Why?
Corneal Transplantation
1
2024
1
0.230
Why?
Recurrence
1
2024
189
0.230
Why?
Corneal Diseases
1
2024
3
0.230
Why?
Clarithromycin
1
2023
1
0.220
Why?
Rifabutin
1
2023
1
0.220
Why?
Neuralgia, Postherpetic
1
2024
12
0.220
Why?
Azithromycin
1
2023
3
0.220
Why?
Societies, Medical
1
2023
75
0.220
Why?
Amikacin
1
2023
1
0.210
Why?
Macrolides
1
2023
7
0.210
Why?
Drug Resistance, Bacterial
1
2023
15
0.210
Why?
Odds Ratio
1
2024
673
0.200
Why?
Electronic Health Records
2
2025
698
0.200
Why?
Practice Guidelines as Topic
1
2023
321
0.190
Why?
Pseudomonas aeruginosa
1
2021
2
0.190
Why?
Rheumatology
1
2021
6
0.180
Why?
Sex Factors
2
2019
644
0.160
Why?
Immunosuppressive Agents
2
2014
20
0.140
Why?
Kaplan-Meier Estimate
2
2015
129
0.130
Why?
Respiratory Tract Infections
1
2016
50
0.120
Why?
Oregon
3
2024
181
0.120
Why?
Linezolid
1
2015
1
0.120
Why?
Drug Tolerance
1
2015
4
0.120
Why?
Child, Preschool
3
2015
1424
0.120
Why?
Minocycline
1
2014
1
0.120
Why?
Granuloma Annulare
1
2014
1
0.120
Why?
Ofloxacin
1
2014
4
0.120
Why?
Child
4
2015
2497
0.110
Why?
Prognosis
2
2014
609
0.110
Why?
Epiretinal Membrane
1
2014
1
0.110
Why?
Retinal Hemorrhage
1
2014
2
0.110
Why?
Retinal Neovascularization
1
2014
2
0.110
Why?
Carrier State
1
2013
8
0.110
Why?
Staphylococcus aureus
1
2013
5
0.110
Why?
Cross Infection
1
2013
27
0.110
Why?
Secondary Prevention
1
2013
48
0.110
Why?
Herpesvirus 3, Human
2
2024
44
0.110
Why?
Pancreatic Pseudocyst
1
2012
1
0.100
Why?
Drainage
1
2012
4
0.100
Why?
Stents
1
2012
11
0.100
Why?
Optic Neuritis
1
2012
3
0.100
Why?
Pancreatic Ducts
1
2012
6
0.100
Why?
Endoscopy, Gastrointestinal
1
2012
8
0.100
Why?
Antirheumatic Agents
1
2012
11
0.100
Why?
Tumor Necrosis Factor-alpha
1
2012
27
0.100
Why?
Systemic Vasculitis
1
2011
1
0.100
Why?
Cross-Sectional Studies
1
2015
1335
0.090
Why?
Gonadal Hormones
1
2011
1
0.090
Why?
Octodon
1
2011
1
0.090
Why?
Sexual Maturation
1
2011
8
0.090
Why?
Circadian Rhythm
1
2011
17
0.090
Why?
Proportional Hazards Models
1
2012
711
0.090
Why?
HIV Infections
1
2017
707
0.090
Why?
Pandemics
2
2024
287
0.090
Why?
Time Factors
3
2016
1097
0.070
Why?
Datasets as Topic
1
2025
20
0.060
Why?
Administration, Oral
2
2015
85
0.060
Why?
Drug Administration Schedule
2
2015
100
0.060
Why?
Immunoglobulin G
2
2016
29
0.060
Why?
Universities
1
2024
15
0.060
Why?
Vaccines, Synthetic
1
2024
34
0.060
Why?
China
1
2024
132
0.060
Why?
Vaccines, Combined
1
2024
80
0.060
Why?
Cooperative Behavior
1
2024
92
0.050
Why?
Public Health
1
2024
81
0.050
Why?
Animals
2
2016
262
0.050
Why?
RNA, Messenger
1
2023
72
0.050
Why?
Masks
1
2021
6
0.050
Why?
Mass Screening
1
2025
678
0.040
Why?
CD4 Lymphocyte Count
1
2017
181
0.030
Why?
Cause of Death
1
2017
181
0.030
Why?
Viral Load
1
2017
136
0.030
Why?
Bacterial Load
1
2016
3
0.030
Why?
Macaca mulatta
1
2016
6
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2016
4
0.030
Why?
Lymphocyte Activation
1
2016
7
0.030
Why?
Cell Proliferation
1
2016
19
0.030
Why?
T-Lymphocytes
1
2016
8
0.030
Why?
Disease Models, Animal
1
2016
19
0.030
Why?
Antibodies, Bacterial
1
2016
33
0.030
Why?
Cytokines
1
2016
30
0.030
Why?
Biopsy
1
2016
75
0.030
Why?
Dose-Response Relationship, Drug
1
2015
129
0.030
Why?
Age Factors
1
2017
923
0.030
Why?
Tomography, X-Ray Computed
1
2016
211
0.030
Why?
Remission Induction
1
2014
26
0.030
Why?
Confidence Intervals
1
2015
237
0.030
Why?
Fluorescein Angiography
1
2014
7
0.030
Why?
Prednisone
1
2014
6
0.030
Why?
Vision Disorders
1
2014
16
0.030
Why?
Glucocorticoids
1
2014
23
0.030
Why?
Chronic Disease
1
2016
428
0.030
Why?
Receptors, Tumor Necrosis Factor
1
2012
4
0.030
Why?
Etanercept
1
2012
4
0.030
Why?
Adalimumab
1
2012
5
0.030
Why?
Infliximab
1
2012
7
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2012
24
0.030
Why?
Severity of Illness Index
1
2014
455
0.030
Why?
Antibodies, Monoclonal
1
2012
25
0.030
Why?
Running
1
2011
3
0.020
Why?
Sexual Development
1
2011
4
0.020
Why?
Orchiectomy
1
2011
6
0.020
Why?
Smoking
1
2014
484
0.020
Why?
Databases, Factual
1
2012
315
0.020
Why?
Algorithms
1
2012
239
0.020
Why?
Logistic Models
1
2012
928
0.020
Why?
Incidence
1
2012
1269
0.020
Why?
Risk Assessment
1
2012
1103
0.020
Why?
Concepts (168)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente